POS0023: Performance of BASDAI vs. ASDAS in Evaluating Axial Involvement in Patients with PsA Treated with Guselkumab: Pooled Analysis of Two Phase 3 Studies. Klik hier voor de poster
POS0344: BASDAI cut-offs for disease activity corresponding to ASDAS-ESR cut-offs in axial spondylarthritis – Results from the EuroSpA collab
Wilt u meer lezen? Log dan in.